Bird & Bird advised Bpifrance’s Large Venture on Series A financing round of Bioptimus, a specialist in AI applied to innovation in biomedicine

International law firm Bird & Bird advised Bpifrance's Large Venture on its participation in the $41 million Series A financing round of Bioptimus, a biotech company that specialises in AI applied to innovation in biomedicine.

Bpifrance's Large Venture participated alongside Cathay Innovation, who led the round, and Sofinnova Partners, an existing investor, in the Series A financing round, one year after the $35 million Seed round.

The Bird & Bird team consisted of partner Carole Bodin and associate Céline Sol for corporate aspects.

Bioptimus was advised by Jones Day, with partner Renaud Bonnet alongside associates, Jérémie Noel and Vincent Babin.

Bird & Bird, who also advised on Large Venture on its first financing round of Bioptimus, is a regular advisor to Bpifrance.

News & Deals

More News & Deals
Deal Bird & Bird advises Ryde Group on Strategic EV Investment in Atoll Discovery

Aug 19 2025

Read More
Deal Bird & Bird advises MyRepublic on Strategic Broadband Sale to StarHub

Aug 15 2025

Read More
Deal Bird & Bird advises Theon on the acquisition of Kappa Optronics

Aug 12 2025

Read More
Deal Bird & Bird advises shareholders of The Payments Association on partnership with Nineteen Group

Aug 07 2025

Read More
Deal Bird & Bird acts for Cornerstone Investors in US$140m placing by Rockhopper Exploration

Aug 06 2025

Read More
News Bird & Bird boosts Dispute Resolution team in Singapore

Aug 06 2025

Read More

Related capabilities